B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Lorecivivint

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lorecivivint, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

demethylbellidifolin
7 shared targets
leucettamine
6 shared targets
t3
6 shared targets
meridianin
2 shared targets
sel
4 shared targets
seliciclib
6 shared targets
6bio
4 shared targets
at
8 shared targets
Harmine
8 shared targets · score 42.8
meridianin
2 shared targets
Loading evidence profile...

This evidence profile for Lorecivivint is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.